Skip to main content
Premium Trial:

Request an Annual Quote

Europroteome to Develop Breast Cancer Diagnostics with German Consortium

NEW YORK, June 16 - Europroteome of Hennigsdorf, Germany, has signed a research collaboration with a consortium of German academic centers to develop proteomics-based diagnostics for breast cancer, the company said today.


Europroteome will analyze protein expression patterns for several hundred serum samples of breast cancer patients provided by GENICA (the Interdisciplinary Study Group on Gene Environment Interaction and Breast Cancer in Germany), a national scientific network of cancer researchers in Germany.


The goal of the collaborative project is to develop novel non-invasive and blood-based screening tests to identify early-stage breast cancer.


Europroteome will correlate protein expression patterns in the serum samples with medical outcome data. The company said it recently conducted a similar study with the University of Magdeburg to use protein patterns for the identification of patients in early stages of stomach and colon cancer.


The first results from the GENICA project are expected over the next couple of months, Europroteome said.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.